Ruan Pimenta
Overview
Explore the profile of Ruan Pimenta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Maia R, Dos Santos G, Reis S, Viana N, Pimenta R, Guimaraes V, et al.
Rev Col Bras Cir
. 2022 Jul;
49:e20223200.
PMID: 35792806
Introduction: specialists have an urge for biomarkers that can discriminate indolent prostate cancer from aggressive tumors. Ki67 is a proliferation marker, and its expression is associated with the aggressiveness of...
12.
Inoue G, Pimenta R, Camargo J, Viana N, Guimaraes V, Srougi M, et al.
Ann Med Surg (Lond)
. 2022 Apr;
75:103398.
PMID: 35386811
Background: Radical prostatectomy, a standard management approach for localized Prostate Cancer (PC), may cause a stress response associated with immune modulating effects. Regional anesthesia was hypothesized to reduce the immune...
13.
Dos Santos G, Viana N, Pimenta R, de Camargo J, Guimaraes V, Romao P, et al.
Cancer Genet
. 2022 Feb;
262-263:80-90.
PMID: 35134616
Telomere dysfunction is one of the hallmarks of cancer, which puts telomere-associated genes in a prominent position in oncology. The CTC1-STN1-TEN1 (CST) complex is vital for telomere maintenance and participates...
14.
de Moraes R, Pimenta R, Mori F, Dos Santos G, Viana N, Guimaraes V, et al.
Mol Biol Res Commun
. 2022 Jan;
10(4):149-156.
PMID: 35097136
Prostate cancer is the most frequent malignancy affecting men worldwide. Due to the low sensitivity and specificity of the prostate-specific antigen test and the digital rectal exam as screening modalities,...
15.
da Silva Gomes P, Candido P, Ghazarian V, Camargo J, Guimaraes V, Goncalves G, et al.
Mol Biol Rep
. 2021 Oct;
48(12):7947-7952.
PMID: 34708341
Background: Bladder cancer is the leading transitional cell carcinoma affecting men and women with high morbidity and mortality rates, justifying the need to develop new molecular target therapies using microRNAs....
16.
Dos Santos G, Viana N, Pimenta R, Guimaraes V, de Camargo J, Romao P, et al.
J Egypt Natl Canc Inst
. 2021 Sep;
33(1):24.
PMID: 34486082
Background: Telomere dysfunction is one of the hallmarks of cancer and is crucial to prostate carcinogenesis. TERF1 is a gene essential to telomere maintenance, and its dysfunction has already been...
17.
Pimenta R, Viana N, Santos G, Candido P, Guimaraes V, Romao P, et al.
Mol Biol Res Commun
. 2021 Sep;
10(3):141-147.
PMID: 34476267
COVID-19 represents a public health emergency, whose mechanism of which is not fully understood. It is speculated that microRNAs may play a crucial role in host cells after infection by...
18.
Dos Santos G, Viana N, Pimenta R, de Camargo J, Reis S, Leite K, et al.
Mol Biol Res Commun
. 2021 Sep;
10(3):121-129.
PMID: 34476265
The new identified protein telomeric zinc-finger associated protein (TZAP) is a negative regulator of telomere length. Since telomere length and telomere maintenance mechanisms are essential to cancer progression, TZAP is...
19.
Dos Santos V, Dos Santos G, Neto C, Viana N, Pimenta R, Guimaraes V, et al.
Urologia
. 2021 Aug;
89(3):451-455.
PMID: 34346250
Background: Peyronie's disease (PD) is characterized by the formation of fibrous plaque in tunica albuginea, causing several problems in patients. The etiology of this disease is not fully understood, and...
20.
Dos Santos G, Pimenta R, Viana N, Guimaraes V, Romao P, Candido P, et al.
Biochem Biophys Rep
. 2021 Jun;
27:101056.
PMID: 34151032
The infection by COVID-19 is a serious global public health problem. An efficient way to improve this disease's clinical management would be to characterize patients at higher risk of progressing...